IL2RA and primary cutaneous T-cell non-Hodgkin lymphoma: Here, we demonstrated the anti‐cancer activity of TPD7 in cutaneous T cell lymphoma and investigated the underlying mechanism of TPD7 through IL‐2R signalling.